NCT-58

CAT: 0804-HY-145102-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-145102-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
NCT-58 is a potent inhibitor of C-terminal HSP90. NCT-58 does not induce the heat shock response (HSR) due to its targeting of the C-terminal region and elicits anti-tumor activity via the simultaneous downregulation of HER family members as well as inhibition of Akt phosphorylation. NCT-58 kills Trastuzumab-resistant breast cancer stem-like cells. NCT-58 induces apoptosis in HER2-positive breast cancer cells[1].
CAS Number
[2411429-33-7]
UNSPSC
12352005
Target
Apoptosis; HSP
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nct-58.html
Purity
99.63
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2OC(C)(C)C=CC2=C1OC)NC3=CC=C(C(OC)=C3)OCCC4NCCCC4
Molecular Formula
C27H34N2O5
Molecular Weight
466.57
References & Citations
[1]Park S, et al. The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells. Cell Death Discov. 2021;7 (1) :354.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HSP90

Related Products

CatalogName
HY-136311-01NCT-504
HY-112277-01NCT-505
HY-D1107NCT-TFP
HY-112278-01NCT-506
HY-101966-01NCT-503
HY-117240-01NCT-502
HY-18768-01NCT-501
HY-18768ANCT-501 (hydrochloride)
HY-Y0813S1Iron-58
HY-168561NLRP3-IN-58

Alternative Products

CatalogName
MBS3617508-01NCT-58
MBS3602749-01NCT-501
M13578-01NCT-505
MBS5755253NCT-502
MBS5799228NCT-504
MBS5775590NCT-10b
MBS3607012NCT-506
MF-0146903-01NCT-TFP
460613-01NCT-503
MBS3607013NCT-507

Popular Products